Synopsis
0
USDMF
0
KDMF
0
VMF
0
FDA Orange Book
0
Canada
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
68
PharmaCompass offers a list of Isoconazole Nitrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Isoconazole Nitrate manufacturer or Isoconazole Nitrate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Isoconazole Nitrate manufacturer or Isoconazole Nitrate supplier.
PharmaCompass also assists you with knowing the Isoconazole Nitrate API Price utilized in the formulation of products. Isoconazole Nitrate API Price is not always fixed or binding as the Isoconazole Nitrate Price is obtained through a variety of data sources. The Isoconazole Nitrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Isoconazole nitrate, Travogen, Adestan G 100; Fazol; Gyno-Travogen; R 15454 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Isoconazole nitrate, Travogen, Adestan G 100; Fazol; Gyno-Travogen; R 15454, including repackagers and relabelers. The FDA regulates Isoconazole nitrate, Travogen, Adestan G 100; Fazol; Gyno-Travogen; R 15454 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Isoconazole nitrate, Travogen, Adestan G 100; Fazol; Gyno-Travogen; R 15454 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Isoconazole nitrate, Travogen, Adestan G 100; Fazol; Gyno-Travogen; R 15454 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Isoconazole nitrate, Travogen, Adestan G 100; Fazol; Gyno-Travogen; R 15454 supplier is an individual or a company that provides Isoconazole nitrate, Travogen, Adestan G 100; Fazol; Gyno-Travogen; R 15454 active pharmaceutical ingredient (API) or Isoconazole nitrate, Travogen, Adestan G 100; Fazol; Gyno-Travogen; R 15454 finished formulations upon request. The Isoconazole nitrate, Travogen, Adestan G 100; Fazol; Gyno-Travogen; R 15454 suppliers may include Isoconazole nitrate, Travogen, Adestan G 100; Fazol; Gyno-Travogen; R 15454 API manufacturers, exporters, distributors and traders.
click here to find a list of Isoconazole nitrate, Travogen, Adestan G 100; Fazol; Gyno-Travogen; R 15454 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Isoconazole nitrate, Travogen, Adestan G 100; Fazol; Gyno-Travogen; R 15454 Drug Master File in Japan (Isoconazole nitrate, Travogen, Adestan G 100; Fazol; Gyno-Travogen; R 15454 JDMF) empowers Isoconazole nitrate, Travogen, Adestan G 100; Fazol; Gyno-Travogen; R 15454 API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Isoconazole nitrate, Travogen, Adestan G 100; Fazol; Gyno-Travogen; R 15454 JDMF during the approval evaluation for pharmaceutical products. At the time of Isoconazole nitrate, Travogen, Adestan G 100; Fazol; Gyno-Travogen; R 15454 JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Isoconazole nitrate, Travogen, Adestan G 100; Fazol; Gyno-Travogen; R 15454 suppliers with JDMF on PharmaCompass.
A Isoconazole nitrate, Travogen, Adestan G 100; Fazol; Gyno-Travogen; R 15454 CEP of the European Pharmacopoeia monograph is often referred to as a Isoconazole nitrate, Travogen, Adestan G 100; Fazol; Gyno-Travogen; R 15454 Certificate of Suitability (COS). The purpose of a Isoconazole nitrate, Travogen, Adestan G 100; Fazol; Gyno-Travogen; R 15454 CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Isoconazole nitrate, Travogen, Adestan G 100; Fazol; Gyno-Travogen; R 15454 EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Isoconazole nitrate, Travogen, Adestan G 100; Fazol; Gyno-Travogen; R 15454 to their clients by showing that a Isoconazole nitrate, Travogen, Adestan G 100; Fazol; Gyno-Travogen; R 15454 CEP has been issued for it. The manufacturer submits a Isoconazole nitrate, Travogen, Adestan G 100; Fazol; Gyno-Travogen; R 15454 CEP (COS) as part of the market authorization procedure, and it takes on the role of a Isoconazole nitrate, Travogen, Adestan G 100; Fazol; Gyno-Travogen; R 15454 CEP holder for the record. Additionally, the data presented in the Isoconazole nitrate, Travogen, Adestan G 100; Fazol; Gyno-Travogen; R 15454 CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Isoconazole nitrate, Travogen, Adestan G 100; Fazol; Gyno-Travogen; R 15454 DMF.
A Isoconazole nitrate, Travogen, Adestan G 100; Fazol; Gyno-Travogen; R 15454 CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Isoconazole nitrate, Travogen, Adestan G 100; Fazol; Gyno-Travogen; R 15454 CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Isoconazole nitrate, Travogen, Adestan G 100; Fazol; Gyno-Travogen; R 15454 suppliers with CEP (COS) on PharmaCompass.
A Isoconazole nitrate, Travogen, Adestan G 100; Fazol; Gyno-Travogen; R 15454 written confirmation (Isoconazole nitrate, Travogen, Adestan G 100; Fazol; Gyno-Travogen; R 15454 WC) is an official document issued by a regulatory agency to a Isoconazole nitrate, Travogen, Adestan G 100; Fazol; Gyno-Travogen; R 15454 manufacturer, verifying that the manufacturing facility of a Isoconazole nitrate, Travogen, Adestan G 100; Fazol; Gyno-Travogen; R 15454 active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Isoconazole nitrate, Travogen, Adestan G 100; Fazol; Gyno-Travogen; R 15454 APIs or Isoconazole nitrate, Travogen, Adestan G 100; Fazol; Gyno-Travogen; R 15454 finished pharmaceutical products to another nation, regulatory agencies frequently require a Isoconazole nitrate, Travogen, Adestan G 100; Fazol; Gyno-Travogen; R 15454 WC (written confirmation) as part of the regulatory process.
click here to find a list of Isoconazole nitrate, Travogen, Adestan G 100; Fazol; Gyno-Travogen; R 15454 suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Isoconazole nitrate, Travogen, Adestan G 100; Fazol; Gyno-Travogen; R 15454 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Isoconazole nitrate, Travogen, Adestan G 100; Fazol; Gyno-Travogen; R 15454 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Isoconazole nitrate, Travogen, Adestan G 100; Fazol; Gyno-Travogen; R 15454 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Isoconazole nitrate, Travogen, Adestan G 100; Fazol; Gyno-Travogen; R 15454 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Isoconazole nitrate, Travogen, Adestan G 100; Fazol; Gyno-Travogen; R 15454 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Isoconazole nitrate, Travogen, Adestan G 100; Fazol; Gyno-Travogen; R 15454 suppliers with NDC on PharmaCompass.
Isoconazole nitrate, Travogen, Adestan G 100; Fazol; Gyno-Travogen; R 15454 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Isoconazole nitrate, Travogen, Adestan G 100; Fazol; Gyno-Travogen; R 15454 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Isoconazole nitrate, Travogen, Adestan G 100; Fazol; Gyno-Travogen; R 15454 GMP manufacturer or Isoconazole nitrate, Travogen, Adestan G 100; Fazol; Gyno-Travogen; R 15454 GMP API supplier for your needs.
A Isoconazole nitrate, Travogen, Adestan G 100; Fazol; Gyno-Travogen; R 15454 CoA (Certificate of Analysis) is a formal document that attests to Isoconazole nitrate, Travogen, Adestan G 100; Fazol; Gyno-Travogen; R 15454's compliance with Isoconazole nitrate, Travogen, Adestan G 100; Fazol; Gyno-Travogen; R 15454 specifications and serves as a tool for batch-level quality control.
Isoconazole nitrate, Travogen, Adestan G 100; Fazol; Gyno-Travogen; R 15454 CoA mostly includes findings from lab analyses of a specific batch. For each Isoconazole nitrate, Travogen, Adestan G 100; Fazol; Gyno-Travogen; R 15454 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Isoconazole nitrate, Travogen, Adestan G 100; Fazol; Gyno-Travogen; R 15454 may be tested according to a variety of international standards, such as European Pharmacopoeia (Isoconazole nitrate, Travogen, Adestan G 100; Fazol; Gyno-Travogen; R 15454 EP), Isoconazole nitrate, Travogen, Adestan G 100; Fazol; Gyno-Travogen; R 15454 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Isoconazole nitrate, Travogen, Adestan G 100; Fazol; Gyno-Travogen; R 15454 USP).
